Si-Bone (SIBN) Return on Capital Employed (2018 - 2026)
Si-Bone's (SIBN) quarterly Return on Capital Employed came in at 9.1% in Q1 2026, up 587.0% year-on-year from 1.32% in Q1 2025, and up 13.96% quarter-over-quarter from 10.58% in Q4 2025.
Si-Bone (SIBN) Return on Capital Employed (2018 - 2026) Analysis & Trends
Si-Bone's Return on Capital Employed history runs 9 years deep, the most recent figure standing at 9.1% for Q1 2026.
- On a quarterly basis, Return on Capital Employed rose 587.0% year-over-year to 9.1% in Q1 2026; TTM through Mar 2026 was 9.1%, a 587.0% increase from a year earlier, with the FY2025 full-year figure at 10.67%, up 666.0% from the prior year.
- Return on Capital Employed improved to 9.1% in Q1 2026 per SIBN's latest filing, from 10.58% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 9.1% in Q1 2026 and bottomed at 43.6% in Q4 2022.
- The 5-year median for Return on Capital Employed is 22.65% (2023), against an average of 24.53%.
- Across the five-year window, Return on Capital Employed slumped 1931 bps in 2022 and jumped 2187 bps in 2023, its largest moves.
- Year by year, Return on Capital Employed stood at 43.6% in 2022, then surged by 48 bps to 22.65% in 2023, then rose by 23 bps to 17.49% in 2024, then soared by 40 bps to 10.58% in 2025, then gained by 14 bps to 9.1% in 2026.
- Per Business Quant, the three latest SIBN Return on Capital Employed figures stand at 9.1% (Q1 2026), 10.58% (Q4 2025), and 12.3% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 11.13% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 24.24% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.38% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 9.30% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Si-Bone | 724.02 Mn | 579.33 Mn | 41.94 Mn | -9.10% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.10% |
| Dec 31, 2025 | -10.58% |
| Sep 30, 2025 | -12.30% |
| Jun 30, 2025 | -13.51% |
| Mar 31, 2025 | -14.98% |
| Dec 31, 2024 | -17.49% |
| Sep 30, 2024 | -21.05% |
| Jun 30, 2024 | -22.70% |
| Mar 31, 2024 | -23.12% |
| Dec 31, 2023 | -22.65% |
| Sep 30, 2023 | -21.47% |
| Jun 30, 2023 | -27.77% |
| Mar 31, 2023 | -39.53% |
| Dec 31, 2022 | -43.60% |
| Sep 30, 2022 | -43.33% |
| Jun 30, 2022 | -39.97% |
| Mar 31, 2022 | -33.86% |
| Dec 31, 2021 | -29.47% |
| Sep 30, 2021 | -24.51% |
| Jun 30, 2021 | -20.65% |